First-line hysterectomy for women with low-risk non-metastatic gestational trophoblastic neoplasia no longer wishing to conceive
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 150 (2) , 282-287
Abstract
No abstract availableKeywords
Funding Information
- Ligue Contre le Cancer
- Institut National Du Cancer
This publication has 19 references indexed in Scilit:
- Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13American Journal of Obstetrics and Gynecology, 2016
- Formalised consensus of the European Organisation for Treatment of Trophoblastic Diseases on management of gestational trophoblastic diseasesEuropean Journal of Cancer, 2015
- Effects of Single-Agent and Combination Chemotherapy for Gestational Trophoblastic Tumors on Risks of Second Malignancy and Early MenopauseJournal of Clinical Oncology, 2015
- Contribution of referent pathologists to the quality of trophoblastic diseases diagnosisHuman Reproduction, 2011
- Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasiaAmerican Journal of Obstetrics and Gynecology, 2011
- Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform moleAmerican Journal of Obstetrics and Gynecology, 2010
- Gestational trophoblastic diseaseThe Lancet, 2010
- Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicityAmerican Journal of Obstetrics and Gynecology, 2009
- First epidemiological data from the French Trophoblastic Disease Reference CenterAmerican Journal of Obstetrics and Gynecology, 2007
- FIGO staging for gestational trophoblastic neoplasia 2000International Journal of Gynecology & Obstetrics, 2002